3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Neuroblastoma
17
Glioblastoma
11
Melanoma
5
Brain Neoplasms
5
Rhabdoid Tumor
4
Osteosarcoma
4
Lymphoma
4
Glioma
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Recurrence
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Wilms Tumor
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pinealoma
2
Neurofibromatosis 1
2
Neuroectodermal Tumors, Primitive
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Meningioma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Hepatoblastoma
2
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine
×
CNS
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled